Janux Therapeutics Inc (JANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 27,768 | 51,828 | 52,334 | 48,389 | 52,446 |
| Marketable Securities | 943,145 | 904,558 | 914,233 | 940,604 | 943,565 |
| Receivables | 149 | 35,000 | N/A | N/A | N/A |
| TOTAL | $983,337 | $1,002,049 | $975,887 | $998,086 | $1,005,553 |
| Non-Current Assets | |||||
| PPE Net | 3,260 | 3,546 | 3,852 | 4,314 | 4,688 |
| Other Non-Current Assets | 21,056 | 22,630 | 21,826 | 22,366 | 21,971 |
| TOTAL | $24,316 | $26,176 | $25,678 | $26,680 | $26,659 |
| Total Assets | $1,007,653 | $1,028,225 | $1,001,565 | $1,024,766 | $1,032,212 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,017 | 3,376 | 4,971 | 3,395 | 3,477 |
| Accrued Expenses | 19,513 | 15,476 | 17,633 | 22,156 | 16,029 |
| TOTAL | $60,152 | $58,915 | $24,997 | $27,831 | $21,379 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 35,070 | 37,591 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 18,438 | 19,099 | 19,746 | 20,380 | 20,317 |
| TOTAL | $19,517 | $27,775 | $19,746 | $20,380 | $20,317 |
| Total Liabilities | $79,669 | $86,690 | $44,743 | $48,211 | $41,696 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 61,137 | 60,984 | 60,832 | 60,148 | 60,094 |
| Common Shares | 61 | 60 | 60 | 60 | 59 |
| Retained earnings | -397,715 | -375,743 | -351,382 | -319,436 | -295,123 |
| Other shareholders' equity | -2,305 | 576 | 4,316 | 4,562 | 3,747 |
| TOTAL | $927,984 | $941,535 | $956,822 | $976,555 | $990,516 |
| Total Liabilities And Equity | $1,007,653 | $1,028,225 | $1,001,565 | $1,024,766 | $1,032,212 |